POSTED: Apr. 29, 2008

Dr. Harvey Herschman, Director of JCCC Basic Research Program, discusses molecular imaging technology as an increased ability to diagnose a tumor, monitor its growth, and indicate more quickly whether a patient is responding to treatment.